SEC Form 4 · accession 0001144204-16-113549
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph A Akers
Director
Period of report
Jul 18, 2016
Accepted (ET)
Jul 19, 2016 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2016 | P | 8,000 | $4.95 | A | 8,000 | D | |
| Common Stock | Jul 19, 2016 | P | 5,000 | $4.68 | A | 13,000 | D |
Table II — derivative securities
No Table II lines on this filing.